Stevens-Johnson syndrome secondary prevention: Difference between revisions
Created page with "__NOTOC__ {{Stevens-Johnson syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References==..." |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Stevens-Johnson syndrome}} | {{Stevens-Johnson syndrome}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | |||
Avoidance of medication that has previously been known to cause SJS in the same patient is recommended to prevent the recurrence of disease, which is usually more severe than the first episode and can be fatal. | |||
==Secondary Prevention== | |||
Avoidance of medication that has previously been known to cause SJS in the same patient is recommended to prevent the recurrence of disease, which is usually more severe than the first episode and can be fatal. | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{ | {{WH}} | ||
{{ | {{WS}} | ||
[[Category: (name of the system)]] | |||
Latest revision as of 20:23, 12 September 2018
|
Stevens-Johnson syndrome Microchapters |
|
Differentiating Stevens-Johnson Syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Stevens-Johnson syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Stevens-Johnson syndrome secondary prevention |
|
Risk calculators and risk factors for Stevens-Johnson syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Avoidance of medication that has previously been known to cause SJS in the same patient is recommended to prevent the recurrence of disease, which is usually more severe than the first episode and can be fatal.
Secondary Prevention
Avoidance of medication that has previously been known to cause SJS in the same patient is recommended to prevent the recurrence of disease, which is usually more severe than the first episode and can be fatal.